Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
1d
Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
To lead new department
Picked as defense secretary
NY judge delays key ruling
US ambassador to Israel
15 years for Pentagon leaker
Ratcliffe named CIA director
SCOTUS rejects appeal
Tubman honored as general
New research on Uranus
Emperor penguin found
CA noncitizen vote rejected
Shell wins climate case
Meets w/ president of Israel
Resigns over abuse scandal
Dozens killed in China
Yale to offer new course
EPA to charge methane fee
To file for bankruptcy?
Ex-Notre Dame coach dies
Suspect waives jury trial
Takes job outside WH
NYT tech workers end strike
Israel misses aid deadline?
LA law blocked temporarily
Picked as DHS secretary
Paulson exits Treasury race
Jury awards ex-detainees
October deliveries plunge
Pandemic drinking study
Feedback